Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Citigroup analysts reiterated a Buy rating on Kirby Corporation (NYSE:KEX) on July 31, 2026. Market Context Kirby Corporation operates in the Industrials sector. The…
Read moreRating Change Rosenblatt analysts reiterated a Buy rating on Dolby Laboratories, Inc. (NYSE:DLB) on July 31, 2026. Market Context Dolby Laboratories, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Outperform rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty…
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change Mizuho analysts reiterated a Neutral rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change Goldman Sachs analysts reiterated a Neutral rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Prosperity Bancshares, Inc. (NYSE:PB) on July 31, 2026. Market Context Prosperity Bancshares, Inc.
Read moreRating Change Citigroup analysts reiterated a Neutral rating on Prosperity Bancshares, Inc. (NYSE:PB) on July 31, 2026. Market Context Prosperity Bancshares, Inc.
Read moreRating Change BTIG analysts reiterated a Buy rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read moreRating Change Mizuho analysts reiterated a Outperform rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read moreRating Change Needham analysts reiterated a Buy rating on Tempus AI, Inc. (NASDAQ:TEM) on July 31, 2026. Market Context Tempus AI, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on Huntington Ingalls Industries, Inc. (NYSE:HII) on July 31, 2026. Market Context Huntington Ingalls Industries, Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Omega Healthcare Investors, Inc. (NYSE:OHI) on July 31, 2026. Market Context Omega Healthcare Investors,…
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Clean Harbors, Inc. (NYSE:CLH) on July 31, 2026. Market Context Clean Harbors, Inc.
Read more
